About The Rx Consultant

The Rx Consultant is a subscription-based service that delivers practical updates & reviews covering all the top-selling drugs and common health conditions. Our publications focus on the facts busy front-line pharmacists and other health care practitioners need to stay current, and provide it a streamlined, easy reading style.

Founded in 1991, The Rx Consultant has subscribers throughout the United States, Canada & The United Kingdom. For 27 years, pharmacists, nurse practitioners and pharmacy technicians have relied on The Rx Consultant for accurate, unbiased updates they can trust. We are completely independent of the pharmaceutical industry and has no commercial bias.

→ Visit The Rx Consultant

Rx Blog users - Save 40% on a subscription to
The Rx Consultant

Use Promo Code RXBLOG18

→ Subscribe Now

Sodium glucose co-transporter 2 (SGLT2) inhibitors are a relatively new class of drugs recommended for people with type 2 diabetes whose blood sugar numbers are too high. The available medications are canagliflozin (Invokana™), dapagliflozin (Farxiga™), and empagliflozin (Jardiance®). These drugs lower a person’s blood sugar by causing the kidneys to remove sugar from the blood and put it in the urine. The extra blood sugar leaves the body when the person urinates.

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!

Share This